Thomas Dunlap

Chief Executive Officer

Professional Overview
Thomas Dunlap is an accomplished executive with extensive experience in the medical device and ophthalmology industries. As the Chief Executive Officer of TECLens and an independent board member for Eyedetec Medical and WaveFront Dynamics Inc., he brings a wealth of strategic and operational expertise to drive innovation and growth.

Experience Summary

Current Roles
As the Chief Executive Officer of TECLens since June 2024, Thomas is responsible for setting the strategic direction, overseeing day-to-day operations, and leading the company's efforts to develop and commercialize advanced ophthalmic technologies. Additionally, he serves as an independent board member for Eyedetec Medical and WaveFront Dynamics Inc., providing valuable insights and guidance to these organizations.

Career Progression
Prior to his current roles, Thomas was the Principal and Founder of Dunlap Ophthalmology Consulting, where he advised medical device companies on strategic and operational initiatives. He also held the position of Interim Chief Executive Officer at Mynosys Cellular Devices, Inc. and served on their board of directors. Earlier in his career, Thomas held executive roles at leading organizations such as Hoya Surgical Optics, Sand Hill Consulting Associates, Bausch & Lomb Surgical, Posey Company, and Allergan Medical Optics, demonstrating his ability to drive growth and operational excellence.

Academic Background
Thomas holds a relevant educational background, though specific details are not provided.

Areas of Expertise
Thomas Dunlap has extensive expertise in the medical device and ophthalmology industries, with a deep understanding of strategic planning, product development, and commercialization. He has a proven track record of leading successful initiatives and driving innovation to address unmet needs in the market.

Professional Impact
Throughout his career, Thomas has demonstrated a commitment to advancing the field of ophthalmology and medical device technology. His leadership and industry contributions have had a significant impact on the organizations he has been a part of, leading to measurable improvements in financial performance, operational efficiency, and market share.

Conclusion
With his diverse executive experience, strategic acumen, and deep industry knowledge, Thomas Dunlap is well-positioned to continue driving growth and innovation in his current and future roles. As a respected leader in the medical device and ophthalmology sectors, he is committed to leveraging his expertise to create positive change and deliver value to stakeholders.